# Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen

> **NCT01328496** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 14 (actual)

## Conditions studied

- Hematologic Malignancies
- Disorder Related to Transplantation
- Hematopoietic Malignancy

## Interventions

- **DRUG:** Preparative Regimen

## Key facts

- **NCT ID:** NCT01328496
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-15
- **Primary completion:** 2016-10-31
- **Final completion:** 2016-10-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-06-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328496, "Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01328496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*